ES2263028T3 - Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton. - Google Patents

Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton.

Info

Publication number
ES2263028T3
ES2263028T3 ES03765694T ES03765694T ES2263028T3 ES 2263028 T3 ES2263028 T3 ES 2263028T3 ES 03765694 T ES03765694 T ES 03765694T ES 03765694 T ES03765694 T ES 03765694T ES 2263028 T3 ES2263028 T3 ES 2263028T3
Authority
ES
Spain
Prior art keywords
acid
sulfonyl
mixture
compound
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03765694T
Other languages
English (en)
Spanish (es)
Inventor
Michael E. Garst
George Sachs
Jai Moo Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Winston Pharmaceuticals LLC
US Department of Veterans Affairs VA
Original Assignee
University of California
Winston Pharmaceuticals LLC
US Department of Veterans Affairs VA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Winston Pharmaceuticals LLC, US Department of Veterans Affairs VA filed Critical University of California
Application granted granted Critical
Publication of ES2263028T3 publication Critical patent/ES2263028T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
ES03765694T 2002-07-19 2003-07-15 Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton. Expired - Lifetime ES2263028T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19
US397459P 2002-07-19

Publications (1)

Publication Number Publication Date
ES2263028T3 true ES2263028T3 (es) 2006-12-01

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03765694T Expired - Lifetime ES2263028T3 (es) 2002-07-19 2003-07-15 Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton.

Country Status (23)

Country Link
US (3) US6897227B2 (US06897227-20050524-C00022.png)
EP (1) EP1556371B1 (US06897227-20050524-C00022.png)
JP (1) JP4463103B2 (US06897227-20050524-C00022.png)
KR (2) KR100788778B1 (US06897227-20050524-C00022.png)
AT (1) ATE323695T1 (US06897227-20050524-C00022.png)
AU (1) AU2003259154B2 (US06897227-20050524-C00022.png)
BR (1) BR0312802A (US06897227-20050524-C00022.png)
CA (1) CA2492718C (US06897227-20050524-C00022.png)
CO (1) CO5690576A2 (US06897227-20050524-C00022.png)
DE (1) DE60304726T2 (US06897227-20050524-C00022.png)
DK (1) DK1556371T3 (US06897227-20050524-C00022.png)
ES (1) ES2263028T3 (US06897227-20050524-C00022.png)
HK (1) HK1079207A1 (US06897227-20050524-C00022.png)
IL (1) IL166371A0 (US06897227-20050524-C00022.png)
MX (1) MXPA05000657A (US06897227-20050524-C00022.png)
NO (1) NO20050801L (US06897227-20050524-C00022.png)
NZ (1) NZ538221A (US06897227-20050524-C00022.png)
PL (1) PL375255A1 (US06897227-20050524-C00022.png)
PT (1) PT1556371E (US06897227-20050524-C00022.png)
RU (1) RU2292342C2 (US06897227-20050524-C00022.png)
TW (1) TW200502231A (US06897227-20050524-C00022.png)
WO (1) WO2004009583A2 (US06897227-20050524-C00022.png)
ZA (1) ZA200501116B (US06897227-20050524-C00022.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US7211590B2 (en) * 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
KR20060041224A (ko) * 2003-07-15 2006-05-11 알러간, 인코포레이티드 양성자 펌프 억제제의 이성질체적으로 순수한 프로드러그를제조하는 방법
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
WO2005082338A2 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Prodrugs for the intravenous administration of proton pump inhibitors
BRPI0507784A (pt) * 2004-02-18 2007-07-17 Allergan Inc métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
EP1722794A1 (en) * 2004-03-11 2006-11-22 Allergan, Inc. Methods and compositions for the treatment of conditions related to gastric acid secretion
PT1740571E (pt) 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
US20070265311A1 (en) * 2006-01-10 2007-11-15 Rubino Mark P Therapeutic Salt Compositions and Methods
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20100113524A1 (en) * 2006-09-19 2010-05-06 Garst Michael E Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
US20100265240A1 (en) * 2007-10-05 2010-10-21 Lg Electronics Inc. Plasma display device
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
WO2012051036A1 (en) 2010-10-11 2012-04-19 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as crth2 antagonists
EP2661265B1 (en) 2010-12-23 2017-03-08 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as crth2 receptor modulators
RU2589709C2 (ru) 2010-12-23 2016-07-10 Мерк Шарп Энд Домэ Корп. Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2
CA2973370A1 (en) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4758597A (en) * 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) * 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
WO1991019712A1 (en) * 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
RO117792B1 (ro) * 1994-06-10 2002-07-30 Byk Gulden Lomberg Chem Fab Arilalchiltioalchil-tiopiridine substituite, utilizate pentru combaterea bacteriilor helicobacter
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
CN100396675C (zh) * 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
CA2714085C (en) * 1998-08-12 2013-02-05 Emory University Method of manufacture of 1,3-oxathiolane nucleosides
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) * 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
CA2425363A1 (en) 2000-10-12 2003-04-10 Fumihiko Sato Benzimidazole compounds, process for producing the same and use thereof

Also Published As

Publication number Publication date
BR0312802A (pt) 2005-04-19
PT1556371E (pt) 2006-09-29
WO2004009583A3 (en) 2004-03-18
NO20050801L (no) 2005-02-15
DE60304726T2 (de) 2007-08-09
HK1079207A1 (en) 2006-03-31
KR20070005029A (ko) 2007-01-09
NZ538221A (en) 2006-11-30
CA2492718C (en) 2010-12-21
ZA200501116B (en) 2006-11-29
US6897227B2 (en) 2005-05-24
US20050143423A1 (en) 2005-06-30
AU2003259154C1 (en) 2004-02-09
DE60304726D1 (de) 2006-05-24
AU2003259154A1 (en) 2004-02-09
US20040102484A1 (en) 2004-05-27
DK1556371T3 (da) 2006-08-21
IL166371A0 (en) 2006-01-16
JP2005536519A (ja) 2005-12-02
JP4463103B2 (ja) 2010-05-12
KR100788778B1 (ko) 2007-12-27
KR100822981B1 (ko) 2008-04-16
EP1556371A2 (en) 2005-07-27
AU2003259154B2 (en) 2006-12-07
CA2492718A1 (en) 2004-01-29
TW200502231A (en) 2005-01-16
RU2292342C2 (ru) 2007-01-27
EP1556371B1 (en) 2006-04-19
KR20050047078A (ko) 2005-05-19
US20050182101A1 (en) 2005-08-18
RU2005105564A (ru) 2005-10-10
ATE323695T1 (de) 2006-05-15
CO5690576A2 (es) 2006-10-31
PL375255A1 (en) 2005-11-28
WO2004009583A2 (en) 2004-01-29
MXPA05000657A (es) 2005-08-19

Similar Documents

Publication Publication Date Title
ES2263028T3 (es) Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton.
JP4346243B2 (ja) プロトン・ポンプ・インヒビターのプロドラッグ
ES2293988T3 (es) Procedimiento para producir un cristal.
ES2525252T3 (es) Agentes antihelmínticos y su uso
US6093734A (en) Prodrugs of proton pump inhibitors
JP4634144B2 (ja) ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
ES2375298T3 (es) Procedimiento para preparar derivados de sulfóxido sustituidos.
JP2002537336A (ja) ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法
KR20060041224A (ko) 양성자 펌프 억제제의 이성질체적으로 순수한 프로드러그를제조하는 방법
PT91198B (pt) Processo para a preparacao de derivados antiulcera da (alquilditio) quinolina
RU2232159C2 (ru) Производные бензимидазола и фармацевтические композиции, содержащие пролекарство ингибитора протонного насоса
KR100847635B1 (ko) 벤즈이미다졸 유도체와 아민과의 염
CZ2001457A3 (cs) Proléčiva inhibitorů protonové pumpy